Microheart Medical Technology
Hemodynamics, without the catheter.
We build EchoPH, an echocardiography-based AI platform for hemodynamic assessment in pulmonary hypertension — screening patients earlier and quantifying disease over time, without catheterization at every step.
The problem
A pressure that builds quietly — for years.
Picture the heart as a pump pushing blood through the lungs. When those vessels narrow, pressure climbs — often for years — while symptoms remain ordinary: breathlessness, fatigue.
The measurement that settles diagnosis and treatment is right-heart catheterization. It is definitive. It is also invasive, hard to repeat, and poorly suited to finding disease early.
Echocardiography is accessible and already part of clinical workflow, but today it does not deliver catheter-grade quantitative hemodynamics. Patients wait. Many wait too long.
Five-year survival in pulmonary arterial hypertension is on the order of major cancers, with median survival around 66 months even under modern therapy.
Five-year survival: PAH sits among the deadliest cancers
Share of patients alive five years after diagnosis
| Condition | Five-year survival |
|---|---|
| Lung cancer | 19.7% |
| Pulmonary arterial hypertension | 20.8% |
| Stomach cancer | 35.1% |
| Colorectal cancer | 56.9% |
| Prostate cancer | 66.4% |
| Breast cancer | 82.0% |
Illustrative comparison. Cancer figures: 17 Chinese cancer registries, 2012–2015. PAH: idiopathic and familial series.
The platform
EchoPH
An echocardiography-based AI platform for non-invasive hemodynamic assessment in pulmonary hypertension — built to screen at scale and quantify over time.
| Right-heart catheterization | Echo + EchoPH | |
|---|---|---|
| Role today | Gold-standard mPAP / PVR | Accessible imaging + AI quantification |
| Invasiveness | Invasive procedure | Non-invasive |
| Repeat use | Limited | Designed for serial visits |
| Workflow | Dedicated procedure | Fits routine echo pathways |
A catheter captures one moment. EchoPH follows the whole course.
one moment
every visit
Right-heart catheterization anchors diagnosis. EchoPH is meant to cover everything around it — from first suspicion through treatment and follow-up, quantified at each visit on ultrasound machines already in the room.
01
Screen
Identify people earlier, inside echo workflows clinics already run — without new capital equipment or an invasive step.
02
Quantify
Estimate hemodynamics and track them across visits to guide therapy and judge whether treatment is working.
Contact
Working on pulmonary hypertension? We'd like to talk.
Microheart Medical Technology Limited